420 with CNW — Goldleaf Guided Journals: The Best for At-Home Marijuana Growers

February 19, 2021 04:25:08

If you have an obsession with buying notebooks, or just like them generally, and you also like and grow your own medical cannabis, then a Goldleaf guided journal may be perfect for you.

A Goldleaf guided journal is a minimalist notebook for marijuana home-growers as well asrecreational and medical users of the plant. Each journal comes with industry and medical advice supported by experts, ideal information for individuals who may be looking to deepen their understanding about the medicinal plant.

In particular, the grow planner adheres to marijuana farmers’ tradition of taking comprehensive notes to help compare the failures and successes of grows with time. This planner comes in a Moleskine-esque stylish design that has been tailored to suit the needs of intermediate and beginner marijuana home growers.

Charles McElroy, the founder of the company that makes Goldleaf planners, explained that the grow planner was suitable for individuals who would like to learn more about their craft. He added that Goldleaf’s intended customers were growers who were similar to him, describing himself as a self-confessed perfectionist who would like to learn from past errors and improve upon those mistakes.

This means that the journal wouldn’t be suitable for first-time marijuana growers or total beginners. However, beginners who would still like to use the Goldleaf Journal would have to conduct research on various soil-less growing methods as well as the basics of soil, light, nutrients and pH controls before they started growing.

Despite this, however, the grow journals are useful in helping growers keep track of their progress, if they have already made a decision on the different methods they’ll be using.

The grow journal comes in two types: the longer grow journal and the smaller grow jotter. While the latter is made up of two-page spreads for users to help track their plants’ nutrient regimens, a section for tracking cultivar particulars and templated day-to-day entry pages, the former is made up of these features, in addition to pages for tasting notes, a chart for plotting a plant’s health and month-to-month and yearly calendars.

Furthermore, when either journal is purchased, the owner receives a set of grower reference cards that contain tips on various things, such as how to diagnose a plant’s health issues or how to calculate how much energy is being used.

McElroy also explained that the idea behind Goldleaf was to find a way to show the science behind marijuana in a way that was more mature and digestible.

People who are growing their own medical cannabis may be glad to know that XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is set to conduct trials for a number of its cannabinoid-based treatments for spasticity linked to MS, Parkinson’s disease and other conditions.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.